文献速递白血病血栓与止血

非M(3)型急性髓系白血病合并弥散性血管内凝血的危险因素与预后

[Risk factors and prognosis of disseminated intravascular coagulation in patients with non-M(3) acute myeloid leukemia].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2026-01-01

本研究回顾性分析407例初治非M(3)型AML患者,依据ISTH-2018 DIC评分分为DIC组109例和非DIC组298例。DIC组高白细胞计数、骨髓原始细胞比例、乳酸脱氢酶及NPM1突变等是DIC独立危险因素,且DIC组早期重度出血发生率更高、完全缓解率更低、总生存更差。

要点

  • 高白细胞计数、高原始细胞比例、高乳酸脱氢酶及NPM1突变是非M(3)型AML发生DIC的独立危险因素。
  • 合并DIC患者早期重度出血风险更高,首疗程诱导化疗完全缓解率更低。
  • DIC是影响非M(3)型AML患者总生存的独立危险因素,尤其在ELN2022高危亚组中生存更差。

核心结论

  • 非M(3)型AML合并DIC与高肿瘤负荷及特定分子学异常密切相关,并伴随更高的早期出血风险和更差的生存结局。

研究设计与样本

  • 回顾性分析2016至2024年苏州大学附属第一医院407例初治非M(3)型AML患者,依据ISTH-2018 DIC评分分为DIC组109例和非DIC组298例。

主要发现

  • DIC组外周血白细胞计数、骨髓原始细胞比例、丙氨酸转氨酶、天冬氨酸转氨酶及乳酸脱氢酶水平均显著高于非DIC组(均P<0.001)。
  • NPM1、FLT3-ITD及SETD2突变在DIC组中显著富集(均P<0.05)。
  • DIC组早期重度出血发生率更高(P<0.001),首疗程诱导化疗完全缓解率更低(P<0.05)。
  • 在总人群中,尤其在ELN2022危险分层高危亚组中,DIC组总生存明显差于非DIC组(P<0.05)。

关键数值与推荐

  • Logistic多因素分析:高白细胞计数、原始细胞比例升高、乳酸脱氢酶升高及NPM1突变是DIC发生的独立危险因素(均P<0.05)。
  • Cox多因素分析:合并DIC、早期重度出血及高龄是影响非M(3)型AML患者总生存的独立危险因素(均P<0.05)。

临床怎么用

  • 对非M(3)型AML患者应早期评估DIC风险,尤其关注高白细胞计数、高原始细胞比例、高乳酸脱氢酶及NPM1突变者。
  • 合并DIC提示更高危临床特征,需加强早期监测出血并实施风险分层管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study retrospectively analyzed 407 newly diagnosed patients with non-M(3) acute myeloid leukemia (AML) treated at the First Affiliated Hospital of Soochow University between 2016 and 2024. Based on the ISTH-2018 DIC score, patients were classified into a DIC group (n=109) and a non-DIC group (n=298), and their clinical characteristics and survival were compared. The results showed that white blood cell count, bone marrow blast percentage, alanine aminotransferase, aspartate aminotransferase, and lactate dehydrogenase levels were significantly higher in the DIC group than in the non-DIC group (all P<0.001). Molecular analysis indicated that NPM1, FLT3-ITD, and SETD2 mutations were significantly enriched in the DIC group (all P<0.05). Multivariable logistic regression showed that a high white blood cell count, a high blast percentage, an elevated lactate dehydrogenase level, and NPM1 mutation were independent risk factors for DIC (all P<0.05). Clinical outcome analysis showed that the DIC group had a higher incidence of early severe bleeding (P<0.001) and a lower complete remission rate after first induction chemotherapy (P<0.05). In the overall population, especially in the European LeukemiaNet (ELN) 2022 high-risk subgroup, overall survival (OS) was significantly worse in the DIC group than in the non-DIC group (P<0.05). Multivariable Cox regression further confirmed that concomitant DIC, early severe bleeding, and older age were independent risk factors for OS in patients with non-M(3) AML (all P<0.05). These findings suggest that DIC in non-M(3) AML is closely associated with a high tumor burden and specific molecular abnormalities and is accompanied by a higher risk of early bleeding and poorer survival outcomes. DIC may therefore represent a higher-risk clinical feature requiring enhanced early monitoring and risk-stratified management. 本研究回顾性分析2016至2024年苏州大学附属第一医院407例初治非M(3)型急性髓系白血病(AML)患者,依据ISTH-2018弥散性血管内凝血(DIC)评分分为DIC组109例和非DIC组298例,比较两组的临床特征及生存差异。结果显示,DIC组外周血白细胞计数、骨髓原始细胞比例、丙氨酸转氨酶、天冬氨酸转氨酶及乳酸脱氢酶水平均显著高于非DIC组(均P<0.001);分子学分析提示,NPM1、FLT3-ITD及SETD2突变在DIC组中显著富集(均P<0.05)。Logistic多因素分析表明,高白细胞计数、原始细胞比例升高、乳酸脱氢酶升高及NPM1突变是DIC发生的独立危险因素(均P<0.05)。临床结局分析显示,DIC组早期重度出血发生率更高(P<0.001),首疗程诱导化疗完全缓解率更低(P<0.05);在总人群中,尤其在ELN2022危险分层高危亚组中,DIC组总生存明显差于非DIC组(P<0.05)。Cox多因素分析进一步证实,合并DIC、早期重度出血及高龄是影响非M(3)型AML患者总生存的独立危险因素(均P<0.05)。上述结果提示,非M(3)型AML合并DIC与较高肿瘤负荷及特定分子学异常密切相关,并伴随更高的早期出血风险和更差的生存结局,提示DIC可能代表一类更高危的临床特征,需加强早期监测与分层管理。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Han MXQ, Xu XY, Wang H, et al. [Risk factors and prognosis of disseminated intravascular coagulation in patients with non-M(3) acute myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2026. PMID: 42706159. doi:10.3760/cma.j.cn121090-20251125-00548

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。